Cargando…
Adenosine and Stroke: Maximizing the Therapeutic Potential of Adenosine as a Prophylactic and Acute Neuroprotectant
Stroke is a leading cause of morbidity and mortality in the United States. Despite intensive research into the development of treatments that lessen the severity of cerebrovascular injury, no major therapies exist. Though the potential use of adenosine as a neuroprotective agent in the context of st...
Autores principales: | Williams-Karnesky, Rebecca L, Stenzel-Poore, Mary P |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769005/ https://www.ncbi.nlm.nih.gov/pubmed/20190963 http://dx.doi.org/10.2174/157015909789152209 |
Ejemplares similares
-
LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury
por: Vartanian, Keri B, et al.
Publicado: (2011) -
Adenosine and adenosine receptors: Newer therapeutic perspective
por: Manjunath, S., et al.
Publicado: (2009) -
Squalenoyl Adenosine Nanoparticles provide Neuroprotection after Stroke and Spinal Cord Injury
por: Gaudin, Alice, et al.
Publicado: (2014) -
Therapeutic potential of adenosine kinase inhibition—Revisited
por: Jarvis, Michael F.
Publicado: (2019) -
Adenosine Receptors as Potential Therapeutic Analgesic Targets
por: Haddad, Mansour, et al.
Publicado: (2023)